Milwaukee Campus-Children's Wisconsin
8915 W Connell Ave, 
Milwaukee, WI 

Overview

Peter Shaw is a Hematologist and an Oncologist in Milwaukee, Wisconsin. His top areas of expertise are Leukemia, Acute Lymphoblastic Leukemia (ALL), Langerhans Cell Histiocytosis, Reticulohistiocytoma, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 25 peer reviewed articles and participating in 17 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Hematology
Oncology

Licenses

Pediatric Hematology-Oncology in WI

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Aspirus Arise Health
  • HMO
  • POS
Children's Community Health
  • EPO
  • PPO
Common Ground Healthcare Cooperative
  • EPO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
Florida Blue
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 6 Less Insurance Carriers -

Locations

Milwaukee Campus-Children's Wisconsin
8915 W Connell Ave, Milwaukee, WI 53226

Additional Areas of Focus

Dr. Shaw has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


17 Clinical Trials

A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518) in Children and Young Adults With Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)
A Phase 2 Study of Blinatumomab (NSC# 765986) in Combination With Nivolumab (NSC # 748726), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged >/= 1 to < 31 Years Old With First Relapse
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
A Phase 2 Randomized Study of Irinotecan/Temozolomide/Dinutuximab With or Without Eflornithine (DFMO) in Children With Relapsed, Refractory or Progressive Neuroblastoma
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
Key Adverse Events After Childhood Cancer
View 12 Less Clinical Trials
Similar Doctors
Expertise in
3
conditions
Hematology | Oncology
Expertise in
3
conditions
Hematology | Oncology

Childrens Hospital Of Wisconsin Inc

8915 W Connell Ave, 
Milwaukee, WI 
 (0.3 miles away)
Languages Spoken:
English

Robert Montgomery is a Hematologist and an Oncologist in Milwaukee, Wisconsin. Dr. Montgomery is highly rated in 3 conditions, according to our data. His top areas of expertise are Von Willebrand Disease (VWD), Blood Clots, Hemophilia A, and Immune Thrombocytopenic Purpura (ITP).

Expertise in
12
conditions
Hematology | Oncology
Expertise in
12
conditions
Hematology | Oncology

Clinical Cancer Center-Froedtert Hospital

8800 W Doyne Ave, 
Milwaukee, WI 
 (0.1 miles away)
Languages Spoken:
English

Mary Eapen is a Hematologist and an Oncologist in Milwaukee, Wisconsin. Dr. Eapen is highly rated in 12 conditions, according to our data. Her top areas of expertise are Graft Versus Host Disease (GvHD), Anemia, Aplastic Anemia, Bone Marrow Transplant, and Bone Marrow Aspiration.

Expertise in
5
conditions
Hematology | Oncology
Expertise in
5
conditions
Hematology | Oncology

Milwaukee Campus-Children's Wisconsin

8915 W Connell Ave, 
Milwaukee, WI 
 (0.3 miles away)
Languages Spoken:
English

Amanda Brandow is a Hematologist and an Oncologist in Milwaukee, Wisconsin. Dr. Brandow is highly rated in 5 conditions, according to our data. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Hemolytic Anemia, and Bone Marrow Transplant.

Frequently Asked Questions about Dr. Peter Shaw

How do I make an appointment with Dr. Peter Shaw?

You can book an appointment with Dr. Peter Shaw by calling their office at 414-266-2000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Peter Shaw a top-rated expert for Leukemia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Peter Shaw is classified as an Experienced expert for Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Peter Shaw specialize in?

While Dr. Peter Shaw is a Hematology, they have specific expertise in Leukemia, Acute Lymphoblastic Leukemia (ALL), and Langerhans Cell Histiocytosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Peter Shaw participate in research or clinical trials?

Yes. Dr. Peter Shaw has published 25 articles and abstracts on conditions like Leukemia. You can view a list of Dr. Peter Shaw's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Peter Shaw accept my insurance?

Dr. Peter Shaw accepts most major insurance plans, including Anthem BCBS and Aspirus Arise Health. We recommend calling the office directly at 414-266-2000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Shaw's expertise for a condition
ConditionClose
        View All 9 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile